Multiple Sclerosis: all 3,524 studies
Page 34 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- CDP323 Biomarker StudyCompletedNCT00726648Phase 1/2
- Cognitive Testing for the Pain Quality Assessment Scale (PQAS)CompletedNCT00715598
- Lido Workset StudyCompletedNCT00710645
- Gene Expression Profiles in Multiple Sclerosis (MS)CompletedNCT00704834
- A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without TreatmentCompletedNCT00702065
- Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)CompletedNCT00695084Phase 1
- Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)TerminatedNCT00688948Phase 2/3
- A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple SclerosisCompletedNCT00676156Phase 1
- COMPliance With Avonex® PS in Patients With Relapsing-Remitting MSCompletedNCT00675883
- Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)Status unknownNCT00674934Phase 1
- Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) TreatmentWithdrawnNCT00674141Phase 1
- Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to PlaceboCompletedNCT00668343Phase 3
- Minocycline in Clinically Isolated Syndromes (CIS)CompletedNCT00666887Phase 3
- Telephone Intervention for Pain Study (TIPS)CompletedNCT00663663Not applicable
- Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple SclerosisCompletedNCT00645749Phase 1
- Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple SclerosisCompletedNCT00644904Phase 1/2
- Memantine Therapy for Multiple SclerosisTerminatedNCT00638833Phase 2
- Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MSTerminatedNCT00638196Phase 1
- Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic CellsCompletedNCT00630721Not applicable
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.WithdrawnNCT00630383Phase 2
- Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedNCT00629642Phase 4
- Flupirtine as Oral Treatment in Multiple SclerosisTerminatedNCT00623415Phase 2
- Management of Pain in Persons With Multiple SclerosisCompletedNCT00621374Not applicable
- Combination Therapy Using Cellcept and Rebif in RRMSCompletedNCT00618527Early Phase 1
- ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.CompletedNCT00618267
- Motor Imagery Practice in Neurological RehabilitationCompletedNCT00618085Phase 2
- AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MSCompletedNCT00617383
- 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis PatientsCompletedNCT00616733Phase 1
- Atorvastatin in Relapsing-Remitting Multiple SclerosisCompletedNCT00616187Phase 2
- Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy SubjectsTerminatedNCT00612872Phase 1
- Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple SclerosisCompletedNCT00599274
- Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)CompletedNCT00594087Not applicable
- FolateScan in Autoimmune DiseaseCompletedNCT00588393Phase 2
- Dose-Escalation Study of T Cell Vaccine in Multiple SclerosisCompletedNCT00587691Phase 1/2
- How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full DoseTerminatedNCT00574041Phase 4
- Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)CompletedNCT00559702Phase 1
- MUltiple Sclerosis and Extract of Cannabis (MUSEC) StudyTerminatedNCT00552604Phase 3
- Firategrast (SB683699) Surface Area Study in Multiple Sclerosis PatientsCompletedNCT00548769Phase 1
- BENEFIT Extension StudyCompletedNCT00544037
- Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?CompletedNCT00534261Phase 4
- Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple SclerosisTerminatedNCT00532532Phase 2
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple SclerosisCompletedNCT00529581Phase 2
- Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)CompletedNCT00525668Phase 1/2
- Avonex 15 Year Long Term Follow-up StudyCompletedNCT00525343
- Promoting Physical Activity for Persons With Multiple SclerosisCompletedNCT00513448Not applicable
- Whole Body Vibration Therapy in Participants With MS Related Balance DeficitsCompletedNCT00510523Not applicable
- A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose NaltrexoneCompletedNCT00501696Phase 3
- Visual Impairment, Oscillopsia and Multiple SclerosisTerminatedNCT00498199
- Allogeneic Stem Cell Transplantation for the Treatment of Multiple SclerosisWithdrawnNCT00497952Phase 1/2
- Tysabri Observational ProgramCompletedNCT00493298
- Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon BetaCompletedNCT00493116Phase 4
- Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta TherapyCompletedNCT00493077Phase 4
- Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple SclerosisCompletedNCT00492765Phase 4
- GER-009-06-AVX Early Therapy in Multiple SclerosisCompletedNCT00492570
- Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing AntibodiesCompletedNCT00492466Phase 4
- Comparison of Bone Effects With Copaxone and Interferon in Multiple SclerosisCompletedNCT00490906
- IPX056 in Subjects With Established Spasticity Resulting From Multiple SclerosisCompletedNCT00488839Phase 3
- Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323TerminatedNCT00484536Phase 2
- TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of WorldCompletedNCT00483847
- Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple SclerosisCompletedNCT00480181Phase 4
- TYSABRI Global Observational Program in SafetyCompletedNCT00477113
- Optimizing IFN Beta - 1B DoseCompletedNCT00473213Phase 3
- Pregnancy Exposure Registry for Tysabri®CompletedNCT00472992
- Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple SclerosisCompletedNCT00469378Phase 2
- Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple SclerosisTerminatedNCT00468611Phase 3
- Modulation of Plasmacytoid Dendritic Cell Function in Multiple SclerosisCompletedNCT00468182
- One Year Extension Study To Protocol C2/5/TZ:MS-05TerminatedNCT00464958Phase 1/2
- Evaluation of Natalizumab for thE Relief of MS Associated FatiGueCompletedNCT00464074
- Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MSCompletedNCT00463710
- Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With BetaseronCompletedNCT00461396
- Biobank For MS And Other Demyelinating DiseasesActive, not recruitingNCT00445367
- Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)CompletedNCT00439257
- Brain Peripheral Benzodiazepine Receptors in Patients With Multiple SclerosisCompletedNCT00432900Phase 1
- The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple SclerosisCompletedNCT00430599
- Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple SclerosisWithdrawnNCT00429442Phase 3
- A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)CompletedNCT00424788Early Phase 1
- Ambulation Study in Multiple SclerosisCompletedNCT00424359
- Levetiracetam in Central Pain in Multiple Sclerosis(MS)CompletedNCT00423527Phase 4
- Correlation Between Cognitive Functions and MRI in Multiple SclerosisStatus unknownNCT00423111
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple SclerosisStatus unknownNCT00411723Phase 1
- An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple SclerosisTerminatedNCT00398528
- Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)CompletedNCT00395317Phase 2
- Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)CompletedNCT00395200Phase 1/2
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple SclerosisCompletedNCT00393588
- fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to ControlsCompletedNCT00391352
- BHT-3009 Immunotherapy in Relapsing Remitting Multiple SclerosisCompletedNCT00382629Phase 2
- Multiple Sclerosis and Heavy Progressive Resistance TrainingCompletedNCT00381576Not applicable
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple SclerosisCompletedNCT00381264Phase 4
- Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)CompletedNCT00364936Phase 1/2
- Omega-3 Fatty Acid Treatment in Multiple SclerosisCompletedNCT00360906Phase 2/3
- Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant SpasticityCompletedNCT00358293Phase 1/2
- A Study to Evaluate the Effectiveness, Tolerability and Safety of LaquinimodCompletedNCT00349193Phase 2
- Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisCompletedNCT00344253Phase 3
- Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case StudyCompletedNCT00343590Not applicable
- Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic StimulationCompletedNCT00342381Phase 2
- Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisCompletedNCT00342134Phase 2
- Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) KitStatus unknownNCT00338637Phase 2
- Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN TherapyCompletedNCT00336557
- Treadmill Training in Chronic MS: Efficacy and Cost-effectivenessWithdrawnNCT00334100Not applicable
- Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer AcetateStatus unknownNCT00331747Not applicable